Search hospitals > California > Los Angeles

UCLA CARE Center CRS

Claim this profile
Los Angeles, California 90095
Global Leader in HIV Infection
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for AIDS
Conducts research for AIDS-Related Complex
Conducts research for HIV
181 reported clinical trials
3 medical researchers
Photo of UCLA CARE Center CRS in Los Angeles

Summary

UCLA CARE Center CRS is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Human Immunodeficiency Virus Infection, AIDS, AIDS-Related Complex, HIV and other specialties. UCLA CARE Center CRS is involved with conducting 181 clinical trials across 111 conditions. There are 3 research doctors associated with this hospital, such as Ronald Mitsuyasu, MD, Theodoros Kelesidis, MD PHD, and Raphael Landovitz, MD.

Area of expertise

1HIV Infection
Global Leader
UCLA CARE Center CRS has run 153 trials for HIV Infection. Some of their research focus areas include:
CXCR4 negative
R5 positive
CD4⁺
2Human Immunodeficiency Virus Infection
Global Leader
UCLA CARE Center CRS has run 143 trials for Human Immunodeficiency Virus Infection. Some of their research focus areas include:
CD4⁺
CD8⁺
US

Top PIs

Ronald Mitsuyasu, MDUCLA CARE Center9 years of reported clinical research
Studies HIV Infection
Studies Squamous Intraepithelial Lesions
7 reported clinical trials
14 drugs studied
Theodoros Kelesidis, MD PHDUniversity of California Los Angeles3 years of reported clinical research
Studies Lipid Disorders
Studies Cardiovascular Disease
3 reported clinical trials
4 drugs studied
Raphael Landovitz, MDUCLA CARE Center CRS (601)4 years of reported clinical research
Studies Human Immunodeficiency Virus Infection
Studies HIV Infection
1 reported clinical trial
1 drug studied

Clinical Trials running at UCLA CARE Center CRS

Tenofovir
Image of trial facility.

Rectal vs Oral Tenofovir

for HIV Prevention

This is a Phase 2, multi-site, two-period, open label randomized crossover (Period 1 and 2) study. Participants are randomized 1:1 to one of two 8-week on-demand product sequences - TFV douche then oral F/TDF or oral F/TDF then TFV douche - with a 2 to 4-week washout period in between. Domains of safety, acceptability, adherence, and PK/PD (sub-study only) are assessed for each product.
Recruiting1 award Phase 24 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at UCLA CARE Center CRS?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security